Peter Gisel-Ekdahl, Envirotainer CEO
June 7, 2022 02:43 PM EDT
Deals
Pharma
Manufacturing

EQT's in­vest­ment arm and Mubadala ink $3B deal for med­ical freight and stor­age com­pa­ny

Tyler Patchen

News Reporter

EQT’s pri­vate eq­ui­ty fund, EQT X, and Mubadala In­vest­ment Com­pa­ny, the in­vest­ment branch of the Unit­ed Arab Emi­rates, are mak­ing a big in­vest­ment in cold …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

Ex-Kite lead­ers step in at Kyver­na as CEO ex­its af­ter land­ing year's sec­ond-biggest IPO

Pfiz­er tees up Phase 3 test in weight man­age­ment — but in an un­ex­pect­ed area

BioN­Tech rolls out Phase 2 lung can­cer da­ta as VEGF bis­pecifics take cen­ter stage

Im­mat­ics los­es Bris­tol My­er­s' sup­port on Phase 1 bis­pe­cif­ic T cell en­gager

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times